CSI Market
Sign In | Register

Tc Biopharm holdings Plc (TCBP) Annual Balance Sheets

Annual · GAAP · USD millions
Access TCBP quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Tc Biopharm holdings Plc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.50
Cash And Cash Equivalents0.00
Current Tax Assets Current0.00
Cash & Short-term Investments1.00
Trade & Other Current Receivables (IFRS combined total)-
Other Receivables0.00
Notes Receivable, Current0.00
Other Current Assets0.65
Income Taxes, Current0.00
Prepaid Expense And Other Assets Current3.91
Total Current Assets5.77
Equipment/Property/Plant Net0.95
Intangible Assets0.47
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent1.13
Corporation Tax Receivable0.65
Noncurrent Assets-
Trade And Other Current Receivables-
Noncurrent Assets-
Trade And Other Current Receivables-
Noncurrent Assets-
Noncurrent Assets-
Trade And Other Current Receivables-
Operating Lease Right Of Use Asset1.13
Total Assets8.33
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.82
Accrued Liabilities, Current0.00
Derivative Liability, Current DE0.00
Other Liabilities, Current0.33
Taxes Payable0.00
Total Current Liabilities4.15
Long-term Debt Convertible0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Other liabilities, Noncurrent1.17
OperatingLeaseLiabilityNoncurrent1.17
Operating Lease Liability Current0.33
Current Deferred Tax Liabilities-
Trade And Other Current Payables-
Current Derivative Financial Liabilities-
Current Convertible Loan-
Current Lease Liabilities-
Total Liabilities5.32
Stockholders' Equity
Deferred Stock Value0.40
Common Stock Value0.26
Additional Paid In Capital Common Stock54.92
Retained Earnings / Accumulated Deficit-52.56
Other Equity0.00
Common Stockholder's Equity3.01
Total Stockholder's Equity3.80
Liabilities & Stockholder's Equity8.33
4 historic quarters locked

Sign in to unlock the full Tc Biopharm holdings Plc balance sheet history.

Sign In Create Free Account

About Tc Biopharm holdings Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: April 1, 2024
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-24-012486

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License